top of page

Publications

Original Article

The Immune Landscape of Cancer

2018

Authors:

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I

Journal:

Immunity

Volume:

48(4)

Page:

812-830

Review Article

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

2018

Authors:

Butterfield LH, Disis ML, Fox BA, Kaufman DR, Khleif SN, Wang E; Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers.

Journal:

Journal of Immunotherapy Cancer

Volume:

6(1)

Page:

138

Review Article

Next generation approaches for tumor vaccination

Cancer Vaccines

2017

Authors:

Patel A, Kaufman HL, Disis ML.

Journal:

Chinese Clinical Oncology

Volume:

6(2)

Page:

19

Original Article

Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens

T Cell Function & Therapy

2017

Authors:

Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, Mihalik LA, Dang Y, Disis ML, Cohen PA.

Journal:

Oncotarget

Volume:

8(7)

Page:

10785-10808

Review Article

Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer

Cancer Vaccines

2017

Authors:

Watt WC, Cecil DL, Disis ML.

Journal:

Seminars in Immunopathology

Volume:

39(3)

Page:

245-253

Original Article

Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial

Tumor Microenvironment

2017

Authors:

Salazar, LG, Lu, H, Reichow, JL, Childs, JS, Coveler, AL, Higgins, DM, Waisman, J, Allison, KH, Dang, Y, and Disis, ML

Journal:

JAMA Oncology

Volume:

3(7)

Page:

969-973

Original Article

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo

Cancer Vaccines

2017

Authors:

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.

Journal:

Clinical Cancer Research

Volume:

23(13)

Page:

3396-3404

Review Article

Precancer Atlas to Drive Precision Prevention Trials

2017

Authors:

Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM.

Journal:

Cancer Research

Volume:

77(7)

Page:

1510-1541

Review Article

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Measuring Human Immunity

2017

Authors:

Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.

Journal:

Journal of Immunotherapy of cancer

Volume:

5

Page:

44

Original Article

Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer

Clinical Trials

2017

Authors:

John B Liao, Ron E Swensen , Kelsie J Ovenell , Katie M Hitchcock-Bernhardt, Jessica L Reichow, Minjun C Apodaca, Leonard D'Amico, Jennifer S Childs, Doreen M Higgins, Barbara J Buening, Barbara A Goff, Mary L Disis

Journal:

Gynecologic Oncology

Volume:

144(3)

Page:

480-485

bottom of page